Article
Prevalence of pyrazinamide resistance across the spectrum of drug resistant phenotypes of Mycobacterium tuberculosis.
Tuberculosis (Edinburgh, Scotland) - 1 Jul 2016
Whitfield Michael G, Streicher Elizabeth M, Dolby Tania, Simpson John A, Sampson Samantha L, Van Helden Paul D, Van Rie Annelies, Warren Robin M
Abstract excerpt
Pyrazinamide resistance is largely unknown in the spectrum of drug resistant phenotypes. We summarize data on PZA resistance in clinical isolates from South Africa. PZA DST should be performed when considering its inclusion in treatment of patients with rifampicin-resistant TB or MDR-TB.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.